Skip to Content
Merck
  • Protective effect of naringenin against gentamicin-induced nephrotoxicity in rats.

Protective effect of naringenin against gentamicin-induced nephrotoxicity in rats.

Environmental toxicology and pharmacology (2014-08-17)
Amr A Fouad, Waleed H Albuali, Ahmed Zahran, Wafaey Gomaa
ABSTRACT

The protective effect of naringenin, a flavonoid compound isolated from citrus fruits, was investigated against nephrotoxicity induced by gentamicin (80mgkg(-1)/day, i.p., for eight days) in rats. Naringenin treatment (50mgkg(-1)/day, p.o.) was administered for eight days, starting on the same day of gentamicin administration. Gentamicin caused significant elevations of serum creatinine, and kidney tissue levels of malondialdehyde, nitric oxide, and interleukin-8, and a significant decrease in renal glutathione peroxidase activity. Naringenin treatment significantly ameliorated the changes in the measured biochemical parameters resulted from gentamicin administration. Also, naringenin markedly attenuated the histopathological renal tissue injury observed with gentamicin. Immunohistochemical examinations showed that naringenin significantly reduced the gentamicin-induced expression of kidney injury molecule-1, vascular endothelial growth factor, inducible nitric oxide synthase, and caspase-9, and increased survivin expression in the kidney tissue. It was concluded that naringenin, through its antioxidant and anti-inflammatory effects, may represent a therapeutic option to protect against gentamicin nephrotoxicity.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Creatinine, anhydrous, ≥98%
Sigma-Aldrich
Anti-Survivin antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
Supelco
Creatinine, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
(±)-Naringenin, ≥95%
Sigma-Aldrich
Naringenin, natural (US), 98%
Supelco
(±)-Naringenin, analytical standard